Search
Home
›
Industrial
›
Agilent
Agilent Technologies Cardiac Drugs
Brand
Agilent
File format
PDF
Published
03 July, 2012
Updated
29 September, 2023
MD5 checksum
DAC308CD3C417A5822B35E108DA22C57
PDF
Agilent Technologies Cardiac Drugs PDF
Download PDF
Email the File to Me
More Agilent Manuals
Agilent Technologies USP Method for HPLC - Analysis of Pramoxine
Agilent Technologies Metronidazole: Updating USP Methods
Agilent Technologies USP Method - Rapid Analysis of Dexamethasone
Agilent Technologies USP Method - Triamcinolone Internal Standard Hydrocortisone
Agilent Technologies Narrow-Bore (2.1mm) Separation of Non-Steroidal Anti-Inflammatory Drugs
Agilent Technologies Separation of Tricyclic Antidepressants Metabolites
Agilent Technologies Separation of Morphine Metabolites Extracted from Blood Plasma
Agilent Technologies High-Resolution Chiral Separation of S- R- Norfluoxetine Using Ultron ES-Pepsin
Agilent Technologies Separation of Cephalosporins on ZORBAX XDB-C8
Agilent Technologies Procainamides Metabolites on ZORBAX XDB-C8
Agilent Technologies Bonded-Phase Selectivity - Separation of Local Anesthetics
Agilent Technologies Short Small-Particle Columns for Fast Efficient Separations - Cough-Formula Mixture
Agilent Technologies Opiate Drugs - Basic Compounds Show Good Peak Shape on Rx-Silica
Agilent Technologies Antihistamines - Excellent Resolution of Drug Mixtures
Agilent Surfactants - TX-114
View all Agilent manuals →